Clinical research study to identify a new way to screen for lung cancer. This is an assessment of multi-type cancers using ctDNA in patients who are undergoing routine screening for lung cancer.
Who’s eligible?
- Patients* age 45-85
- One time blood draw completed annually for up to 3 years
- Patient compensation provided for time and participation
If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring by a research doctor.
*WWMG patients are welcome to apply. Patients seen outside of WWMG are accepted, however we will need medical records from your treating physician.
For additional details or if you have questions, please call (425) 225-2780 or email clinicalresearch@wwmedgroup.com.